MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines12080946

Медицинская библиотека · Vaccines · 2024

The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.

Rota Paul A, Evans Roger, Ben Mamou Myriam Corinne, Rey-Benito Gloria, Sangal Lucky, Dosseh Annick, Ghoniem Amany, Byabamazima Charles R, Demanou Maurice, Anderson Raydel, Kim Gimin, Bankamp Bettina, Beard R Suzanne, Crooke Stephen N, Ramachandran Sumathi, Penedos Ana, Stambos Vicki, Nicholson Suellen, Featherstone David, Mulders Mick N

СтатьяПеревод в очереди

Аннотация

With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including global specialized laboratories, regional reference laboratories, national laboratories, and, in some countries, subnational laboratories. Regional networks are supervised by regional laboratory coordinators reporting to a global coordinator at WHO headquarters. Laboratories in the GMRLN have strong links to national disease control and vaccination programs. The GMRLN's goal is to support member states in obtaining timely, complete, and reliable laboratory-based surveillance data for measles and rubella as part of the strategy for achieving measles and rubella elimination. Surveillance data are reported to the national program and are included in annual reports on the status of measles and rubella elimination to national verification committees for review by regional verification commissions. Quality within the GMRLN is ensured by monitoring performance through external quality assurance programs, confirmatory and quality control testing, accreditation, and coordination of corrective action and training where needed. The overall performance of the laboratories has remained high over the years despite many challenges, particularly the COVID-19 pandemic. The GMRLN is well-positioned to support high-quality laboratory-based surveillance for measles and rubella and to transition to supporting laboratory testing for other pathogens, including vaccine-preventable diseases.

Для цитирования: Rota Paul A, Evans Roger, Ben Mamou Myriam Corinne, Rey-Benito Gloria, Sangal Lucky, Dosseh Annick, Ghoniem Amany, Byabamazima Charles R, Demanou Maurice, Anderson Raydel, Kim Gimin, Bankamp Bettina, Beard R Suzanne, Crooke Stephen N, Ramachandran Sumathi, Penedos Ana, Stambos Vicki, Nicholson Suellen, Featherstone David, Mulders Mick N. The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.. Vaccines. 2024. DOI: 10.3390/vaccines12080946.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.